"id","description","instanceType","text","label","name","uuid:ID"
"Objective_1","Main objective","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","","OBJ1","c8fcd91d-b597-47dc-9507-d583e7e5ec48"
"Objective_2","Safety","OBJECTIVE","To document the safety profile of the xanomeline TTS.","","OBJ2","5b006805-f459-4e4e-878c-8e1973acfabe"
"Objective_3","Behaviour","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","","OBJ3","8a204539-2d1c-41de-88ec-cd93e0b108c0"
